Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Victoza (active ingredient:liraglutide) subcutaneous injection Initial FDA Approval: 2010 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
Journal it
LFD is a well-established treatment in IBS, especially IBS-D and IBS-M patients (1115)
Losing weight too quickly can result in unwanted, negative side effects, so Belle Vies medical providers are here to monitor your progress, adjusting dosage as needed, while prioritizing your safety
It advises against using the product which has no medicinal effect
